SLOAN SHELDON (Chief Medical Officer) sold 7.96K shares of SPYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $397.9K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/3/2026ACC: 0001636282-26-000030
Officer· Chief Medical Officer
Since Oct 2024
-7.96K
Net shares
Net seller
$397.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
7.96K acquired · 15.92K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+7.96K
Price / share
$21.66
Trade value
$172.37K
% of position
New position
4/1/2026
0.00→7.96K
Common Stock
Direct
Shares
−7.96K
Price / share
$50.00
Trade value
$397.90K
% of position
New position
4/1/2026
7.96K→0.00
Total
Net shares
+0.00
Net value
-$225.53K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2026 | M · Option Exercise | +7.96K | $21.66 | $172.37K | New position | 0.00 | 7.96K |
| Common Stock Direct | 4/1/2026 | S · Sale | −7.96K | $50.00 | $397.90K | New position | 7.96K | 0.00 |
| Total | +0.00 | -$225.53K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
7.96K shares
Shares
−7.96K
Strike price
21.66
Held after
87.54K
Exercisable
—
4/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock7.96K shares | 4/1/2026 | M · Option Exercise | −7.96K | 21.66 | — | 87.54K |